ATLANTA and SYDNEY – 21 September 2007. Life Therapeutics (ASX: LFE)
today announced that the Board of Directors has received an unsolicited offer of US$50 million cash from Octapharma AG for LFE's 14
operating plasma collection centres and the central testing laboratory.
- Forums
- ASX - By Stock
- LFE
- life therapeutics announces unsolicited cash o
LFE
life therapeutics limited
life therapeutics announces unsolicited cash o
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.